• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Industry Report Card: European Health Care Dec 04 Product Image

Industry Report Card: European Health Care Dec 04

  • Published: December 2004
  • Region: Europe
  • Standard & Poors

FEATURED COMPANIES

  • AstraZeneca PLC
  • Bayer AG
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline PLC
  • Merck KGaA
  • Novartis AG
  • MORE

Abstract
(Editor's note: The tables in this article are designed for exporting in certain Standard & Poor's products; therefore, printing quality may vary. Changing your page orientation to landscape mode, reducing your page margins, and/or reducing the text size in your browser may improve the printed output.) During the third quarter of 2004, growth within the pharmaceutical industry in Western Europe--which represents about 25% of the global market--moderated further to 5% from an average of 6%-7%% during the first half of 2004. This is due to continued negative effects from the ongoing health care reforms, in particular in Germany (market growth of about 4%), France (5%), and Italy (4%), the world's third-, fourth-, and sixth-largest markets, respectively. Pricing pressure is essentially...

Companies mentioned in this report are:
- Bayer AG
- AstraZeneca PLC
- Fresenius Medical Care AG & Co. KGaA
- Novartis AG
- GlaxoSmithKline PLC
- Sanofi
- Fresenius SE & Co. KGaA
- Schering AG
- Nycomed S.C.A. SICAR
- Merck KGaA
- Novo Nordisk A/S

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international READ MORE >

- Bayer AG
- AstraZeneca PLC
- Fresenius Medical Care AG & Co. KGaA
- Novartis AG
- GlaxoSmithKline PLC
- Sanofi
- Fresenius SE & Co. KGaA
- Schering AG
- Nycomed S.C.A. SICAR
- Merck KGaA
- Novo Nordisk A/S

Note: Product cover images may vary from those shown

RELATED PRODUCTS